key: cord-1053062-16crg3k8 authors: Yang, H.; Lan, Y.; Yao, X.; Lin, S.; Xie, B. title: Evaluation on the diagnostic efficiency of different methods in detecting COVID-19. date: 2020-06-26 journal: nan DOI: 10.1101/2020.06.25.20139931 sha: cd9b971f85ae1c71c6e58c22b60b8555bc65a4c6 doc_id: 1053062 cord_uid: 16crg3k8 Objective: To evaluate the diagnostic efficiency of different methods in detecting COVID-19 to provide preliminary evidence on choosing favourable method for COVID-19 detection. Methods: PubMed, Web of Science and Embase databases were searched for identifing eligible articles. All data were calculated utilizing Meta Disc 1.4, Revman 5.3.2 and Stata 12. The diagnostic efficiency was assessed via these indicators including summary sensitivity and specificity, positive likelihood ratio (PLR), negative LR (NLR), diagnostic odds ratio (DOR), summary receiver operating characteristic curve (sROC) and calculate the AUC. Results: 18 articles (3648 cases) were included. The results showed no significant threshold exist. EPlex: pooled sensitivity was 0.94; specificity was 1.0; PLR was 90.91; NLR was 0.07; DOR was 1409.49; AUC=0.9979, Q*=0.9840. Panther Fusion: pooled sensitivity was 0.99; specificity was 0.98; PLR was 42.46; NLR was 0.02; DOR was 2300.38; AUC=0.9970, Q*=0.9799. Simplexa: pooled sensitivity was 1.0; specificity was 0.97; PLR was 26.67; NLR was 0.01; DOR was 3100.93; AUC=0.9970, Q*=0.9800. Cobas: pooled sensitivity was 0.99; specificity was 0.96; PLR was 37.82; NLR was 0.02; DOR was 3754.05; AUC=0.9973, Q*=0.9810. RT-LAMP: pooled sensitivity was 0.98; specificity was 0.99; PLR was 36.22; NLR was 0.04; DOR was 751.24; AUC=0.9905, Q*=0.9596. Xpert Xpress: pooled sensitivity was 0.99; specificity was 0.97; PLR was 27.44; NLR was 0.01; DOR was 3488.15; AUC=0.9977, Q*=0.9829. Conclusions: These methods (ePlex, Panther Fusion, Simplexa, Cobas, RT-LAMP and Xpert Xpress) bear higher sensitivity and specificity, and might be efficient methods complement to the gold standard. Through metagenomic sequencing, SARS-CoV-2 was first identified in BALF (bronchoalveolar lavage fluid) of Chinese patients (10, 20, 21) . Based on the rapid characterization of the full genome of the virus, many molecular diagnostic methods have been developed rapidly. Real-time reverse transcription-polymerase chain reaction (rRT-PCR) is currently the standard of the diagnosis of acute coronavirus disease (COVID-19) (10, 21, 22) . However, rRT-PCR assay has many limitations, such as required high purity samples, trained personnel and time-consuming. This test did not meet the rapidly growing need for virus testing in patients with COVID-19 infection, suspected infection or close contact with confirmed cases, which have significantly hampered public health efforts to contain the outbreak. To resolve this contradiction, the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for multiple SARS-CoV-2 rapid tests beginning in March 2020. Up to now, some studies have been published to comparing the diagnostic features of these methods (23) (24) (25) , whereas the results were inconsistent. Therefore, it is urgent to performed this meta-analysis to comprehensively summarize the characteristics of the diagnostic assay in detecting COVID-19 to provide the preliminary evidence to support further guide clinical routine through evidence-based medicine. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 26, 2020. . https://doi.org/10.1101/2020.06.25.20139931 doi: medRxiv preprint Studies on evaluation of the method for COVID-19 detection in PubMed, Web of Science and Embase databases were thoroughly searched, from their inception till 25 March 2020. The Searching terms include: "PCR", "COVID-19", "SARS-CoV-2", "Corona Virus Disease 2019", "RT-PCR", "diagnosis". The language was limited in English. Pertinent articles were identified by two reviewers after screening titles or abstracts. Duplicated articles were removed by checking duplication. Besides, references of selected articles were screened to find more relevant articles. Disagreement was resolved by the third reviewer. All eligible articles were evaluated by Quadas-2 for systematic reviews of intervention (Version 5.3.0). Articles meeting the following criteria were included in this study: i) the articles studied on the method for detecting COVID-19; ii) patients recruited in articles should include COVID-19 and non-COVID-19; iii) patients defined as COVID-19 or non-COVID-19 were proved by gold standard; iv) data in articles were sufficient to analyze the pooled sensitivity and specificity; v) articles published in English. Incomplete data, reviews and case reports were excluded. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 26, 2020. . https://doi.org/10.1101/2020.06.25.20139931 doi: medRxiv preprint Two reviewers independently pooled the following data from eligible articles: author, year, Country, sample size, methods, true positive (TP), false positive (FP), false negative (FN), true negative (TN). When the extracted data were inconsistent, discrepancies were resolved by discussion or the third reviewer. All statistical analyses were conducted by employing Meta-Disc 1. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 26, 2020. . https://doi.org/10.1101/2020.06.25.20139931 doi: medRxiv preprint After searching three databases, out of 1094 duplicate articles, 3874 articles were identified. Then, 3837 articles were removed by screening the title or abstract. Afterwards, 19 articles were further excluded via thoroughly reading the full-text. Eventually, 18 articles of 3648 cases were included in this meta-analysis. Table 1 All eligible articles were assessed through the Quadas-2 tool. The result suggested that all articles exhibited good quality (Supplementary Figure 2 ). The Spearman correlation coefficient and p-value were utilized to Figure 2F ). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 26, 2020. Figure 5F ). Six articles exhibited this method were included. The results suggested that the pooled sensitivity was 0.98, 95%CI (0.94-0.99) (I 2 =25.5%, Figure 6F ). The funnel plot exhibited that no significant publication bias in analysis on ePlex, Panther Fusion, Simplexa, RT-LAMP, Cobas ® and Xpert Xpress, because of the relatively symmetrical in this funnel plot (all P-value >0.1) (Supplementary Figure 3) . The COVID-19 pandemic is putting enormous pressure on clinical and public health laboratories. The COVID-19 pandemic may be caused by widespread transmission, viral detection is key to isolate positive . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 26, 2020. . https://doi.org/10.1101/2020.06.25.20139931 doi: medRxiv preprint patients and stop viral transmission (44) (45) (46) (47) (48) . rRT-PCR is the most reliable and widely used technology to diagnose viruses including coronaviruses (44) (45) (46) (47) (48) . However, rRT-PCR has some limitations, (21, 47, 51, 52) . This article discusses some of the diagnostic methods include EUA-granted assays. To date, this study was the first meta-analysis on systematically evaluating the diagnostic efficiency of different method for detecting COVID-19. In this study, we analyzed the pooled sensitivity, specificity, PLR, NLR, DOR, AUC and Q* on each methods (ePlex, Panther Fusion, Simplexa, Cobas ® , Xpert Xpress and RT-LAMP), respectively. The results demonstrated that these above methods bear higher sensitivity and specificity, and might be efficient methods complement to the gold standard. The ePlex assay targets the N gene of SARS-CoV-2, which is an in vitro diagnostic test. The ePlex has a relatively short turnaround time, . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 26, 2020. Cobas ® SARS-CoV-2 is a qualitative dual target assay, includes the ORF1/a nonstructural regional unique to SARS-CoV-2 and a region on the E gene, which is conserved across the sarbecovirus subgenus. Cobas ® SARS-CoV-2 is based on fully automated sample preparation (nucleic acid extraction and purification) followed by PCR amplification and detection (53) . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 26, 2020. . https://doi.org/10.1101/2020.06. 25.20139931 doi: medRxiv preprint Automated solutions for molecular diagnostics can help process large numbers of samples, save testing time, allow non -professional operators. The assay has passed clinical evaluation and received EUA from the U.S. FDA (54) (55) (56) . The Xpert Xpress SARS-CoV-2 assay targets two genes, the E-gene (Sarbeco specific) and N2-gene (SARS-CoV-2 specific), which received EUA status on March 20, 2020. The Xpert test platform integrates specimen processing, nucleic acid extraction, reverse transcriptase polymerase chain reaction amplification of SARS-CoV-2 RNA, and amplicon detection in a single cartridge, which improves actionability overall. This assay is simple to operate with the least technical interventions, and FDA has authorized trained non-laboratorians to test. RT-LAMP methodology is regarded as a new generation diagnostics (57) , which was developed by Notomi et al.in 2000(58) . This method has high sensitivity, high specificity, simple method, low cost and time saving, which has been widely applied for the detection of influenza virus, MERS-CoV, West Nile virus, Ebola virus, Zika virus, yellow fever virus, and a variety of other pathogens (59) (60) (61) (62) (63) (64) . The detection results are based on colorimetric display is easy to understand and does not require any expensive equipment which is suitable for countries with limited laboratory capacity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 26, 2020. We also encountered some limitations: i) the sample size of each method for detecting COVID-19 was relatively small. ii) the heterogeneity of some studies was significant though we have divided this meta-analysis based on the different methods, which might affect the stability of results to some extent. Therefore, more well designed study involving the different methods with a large sample size is urgent to be conducted. Summarily, these methods (ePlex, Panther Fusion, Simplexa, Cobas ® , Xpert Xpress and RT-LAMP) bear higher sensitivity and specificity, and might be efficient methods complement to the gold standard. All authors declare no conflict of interest. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 26, 2020. . https://doi.org/10.1101/2020.06.25.20139931 doi: medRxiv preprint Outbreak of a novel coronavirus Return of the Coronavirus: 2019-nCoV A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding The Lancet. Emerging understandings of 2019-nCoV A pneumonia outbreak associated with a new coronavirus of probable bat origin A new coronavirus associated with human respiratory disease in China Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period Coronavirus disease (COVID-19) Situation Report -141. World Health Organization Successful containment of COVID-19: the WHO-Report on the COVID-19 outbreak in China COVID-19) due to SARS-CoV-2 in Hong Kong An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies Author Correction: A new coronavirus associated with human respiratory disease in China Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia A pneumonia outbreak associated with a new coronavirus of probable bat origin Coronavirus and the race to distribute reliable diagnostics Comparison of Abbott ID Now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19 The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens Clinical Evaluation of Three Sample-To-Answer Platforms for the Detection of SARS-CoV-2 Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories Comparison of the Panther Fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2 Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa COVID-19 direct assay Comparison of SARS-CoV-2 detection from nasopharyngeal swab samples by the Roche cobas 6800 SARS-CoV-2 test and a laboratory-developed real-time RT-PCR test Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories Clinical Evaluation of the cobas SARS-CoV-2 Test and a Diagnostic Platform Switch during 48 Hours in the Midst of the COVID-19 Pandemic Multi-center evaluation of cepheid xpert(R) xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic Test Agreement Between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2 Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2 CRISPR-Cas12-based detection of SARS-CoV-2 A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Laboratory Diagnosis of COVID-19: Current Issues and Challenges Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) A mismatch-tolerant RT-quantitative PCR: application to broad-spectrum detection of respiratory syncytial virus A Melting Curve-Based Multiplex RT-qPCR Assay for Simultaneous Detection of Four Human Coronaviruses Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease MERS coronavirus: diagnostics, epidemiology and transmission Clinical evaluation of multiplex RT-PCR assays for the detection of influenza A/B and respiratory syncytial virus using a high throughput system Diagnosis and monitoring of HCV infection using the cobas((R)) HCV test for use on the cobas((R)) 6800/8800 systems Multicenter Comparison Study of both Analytical and Clinical Performance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms Evaluation of the Performance of the Cobas CT/NG Test for Use on the Cobas 6800/8800 Systems for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Male and Female Urogenital Samples Loop mediated isothermal amplification: An innovative gene amplification technique for animal diseases Loop-mediated isothermal amplification of DNA Rapid and sensitive detection of novel avian-origin influenza A (H7N9) virus by reverse transcription loop-mediated isothermal amplification combined with a lateral-flow device A Rapid and Specific Assay for the Detection of Visual Detection of West Nile Virus Using Reverse Transcription Loop-Mediated Isothermal Amplification Combined with a Vertical Flow Visualization Strip Rapid and specific detection of Asian-and African-lineage Zika viruses Survey and Visual Detection of Zaire ebolavirus in Clinical Samples Targeting the Nucleoprotein Gene in Sierra Leone A real-time reverse transcription loop-mediated isothermal amplification assay for the rapid detection of yellow fever virus authors commented on previous versions of the manuscript and approved the final manuscript.